Uncover the strategic role of supply chain in clinical operations by exploring innovative approaches to clinical utilization as it relates to value analysis, physician engagement, and commodity utilization. In this track, gain an all-encompassing view of healthcare supply chain and the many valuable perspectives at play in its efficient operation.

The Clinical Insights Track is from 1:00 PM to 5:00 PM on Monday, April 20. For more information contact Trey Beuttel or call 859.523.5701

1:00 PM - 2:00 PM

Communicating with physician leaders to ensure their strategic engagement in value analysis can have a significant impact on both clinical outcomes and your organization's bottom line. This session examines strategies for bringing physicians into the value analysis process across product standardization, formulary decisions, and high-cost procedures. Gain actionable insights to strengthen physician partnerships, enhance collaboration, and drive more value across clinical operations.

Join leading healthcare supply chain leaders as they discuss engagement initiatives that lead to competitive advantage by engaging physicians as strategic partners rather than stakeholders to manage.

Learning Objectives:
1. Identify opportunities for physician engagement across the value analysis spectrum and analyze key barriers that impact collaboration and outcomes.
1. Apply communication strategies tailored to physician leaders that foster collaboration around product selection, utilization optimization, and efficiency improvements.
3. Distinguish between effective and ineffective approaches to physician engagement based on real-world examples of value analysis initiatives.
4. Formulate actionable plans to strengthen physician partnerships and drive value through improved engagement in the value analysis process.

2:30 PM - 3:30 PM

Clinical utilization represents one of the most significant opportunities for cost reduction and quality improvement in healthcare, yet many organizations struggle to create alignment between supply chain and clinical teams. Explore how cross-functional clinical teams are leveraging automation and data-driven insights to enhance clinical utilization and operational efficiency. Hear from industry thought leaders as they highlight strategies for aligning supply chain and clinical priorities to drive standardization, reduce waste, and improve system-wide performance.

Join industry leaders who have successfully transformed their value analysis processes as they share practical approaches to harnessing utilization data, automating workflows, and building consensus around product standardization initiatives that deliver measurable clinical and financial outcomes.

Learning Objectives:
1. Analyze how automation and data analytics can be integrated into value analysis processes to identify clinical utilization improvement opportunities.
2. Apply cross-functional collaboration strategies to align supply chain and clinical stakeholders around standardization initiatives.
3. Evaluate real-world approaches to reducing waste and variability in clinical utilization.
4. Develop actionable steps to enhance your organization's value analysis framework using data-driven insights and team alignment principles.

4:00 PM - 5:00 PM

The introduction of new medical products and technologies presents both opportunity and risk for IDNs. Without a structured approach to new product entry, supply chains can face uncontrolled spend, clinical variability, and adoption of innovations that fail to deliver promised value. In this session, explore how leading IDNs are building frameworks for evaluating, introducing, and monitoring new products while maintaining the agility needed to embrace genuine clinical advancement.

Hear from supply chain leaders who have successfully implemented new product entry processes that balance innovation with evidence-based decision-making, physician engagement, and financial stewardship.

Learning Objectives:
1. Recognize the key components of an effective new product entry process, from initial request through evaluation, trial, and full adoption or rejection.
2. Apply evaluation criteria that assess clinical evidence, cost-effectiveness, and alignment with organizational priorities when reviewing new product requests.
3. Develop strategies for engaging physicians and clinical stakeholders in structured new product evaluation.
4. Design monitoring and feedback mechanisms that track new product performance post-introduction to ensure sustained value delivery and inform future decisions.

For more information on the IDN Summit, please contact Trey Beuttel.

Trey Beuttel
Director, Provider Relationships and Education
859.523.5701